Tapinarof
≥99%
- Product Code: 102778
CAS:
79338-84-4
| Molecular Weight: | 254.32 g./mol | Molecular Formula: | C₁₇H₁₈O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Tapinarof is primarily used in the treatment of plaque psoriasis, a chronic autoimmune skin condition characterized by red, scaly patches on the skin. It works by modulating the immune response and reducing inflammation, helping to alleviate symptoms and improve skin appearance. The compound is applied topically, making it a convenient option for patients seeking localized treatment without systemic side effects. Its mechanism of action involves targeting the aryl hydrocarbon receptor (AhR), which plays a role in skin barrier function and immune regulation. This targeted approach makes it effective in managing mild to moderate psoriasis, offering an alternative to traditional therapies like corticosteroids or phototherapy. Additionally, its non-steroidal nature reduces the risk of side effects associated with long-term steroid use, such as skin thinning. Tapinarof is particularly beneficial for patients who prefer a non-invasive treatment option or have not responded well to other therapies. Its development represents a significant advancement in dermatological care, providing a novel and effective solution for managing psoriasis.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Light Yellow Solid |
| Purity (%) | 98.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿16,990.00 |
+
-
|
| 0.010 | 10-20 days | ฿29,760.00 |
+
-
|
Tapinarof
Tapinarof is primarily used in the treatment of plaque psoriasis, a chronic autoimmune skin condition characterized by red, scaly patches on the skin. It works by modulating the immune response and reducing inflammation, helping to alleviate symptoms and improve skin appearance. The compound is applied topically, making it a convenient option for patients seeking localized treatment without systemic side effects. Its mechanism of action involves targeting the aryl hydrocarbon receptor (AhR), which plays a role in skin barrier function and immune regulation. This targeted approach makes it effective in managing mild to moderate psoriasis, offering an alternative to traditional therapies like corticosteroids or phototherapy. Additionally, its non-steroidal nature reduces the risk of side effects associated with long-term steroid use, such as skin thinning. Tapinarof is particularly beneficial for patients who prefer a non-invasive treatment option or have not responded well to other therapies. Its development represents a significant advancement in dermatological care, providing a novel and effective solution for managing psoriasis.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :